QURE insider transaction filings
uniQure N.V. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-07. Screen QURE transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | Kapusta Matthew C — CEO, Managing Director, Director | Option exercise (M): 21,082 @ $19.39 · Sale (S): 9,200 @ $44.43 · Sale (S): 4,282 @ $45.43 · Sale (S): 7,600 @ $45.89 · Option exercise (M): 21,082 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Abi-Saab Walid — Chief Medical Officer | Option exercise (M): 10,000 @ $5.59 · Sale (S): 10,000 @ $46.46 · Sale (S): 20,000 @ $46.40 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Kaye Jack — Director | Option exercise (M): 4,107 @ $37 · Sale (S): 4,107 @ $46.49 · Option exercise (M): 17,060 @ $20.18 · Sale (S): 17,060 @ $46.43 · Option exercise (M): 4,107 (derivative) @ $0 · Option exercise (M): 17,060 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Abi-Saab Walid — Chief Medical Officer | Sale (S): 1,434 @ $46.86 | EDGAR |
| 2026-06-26 | 4 | Kapusta Matthew C — CEO, Managing Director, Director | Option exercise (M): 4,128 @ $31.71 · Sale (S): 6,696 @ $50 · Option exercise (M): 28,716 @ $31.71 · Sale (S): 28,716 @ $50.02 · Option exercise (M): 4,128 (derivative) @ $0 · Option exercise (M): 28,716 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Balachandran Madhavan — Director | Option exercise (M): 5,295 @ $31.71 · Option exercise (M): 6,390 @ $19.39 · Sale (S): 5,295 @ $47.08 · Sale (S): 4,700 @ $43.66 · Sale (S): 1,690 @ $42.60 · Option exercise (M): 5,295 (derivative) @ $0 · +1 more | EDGAR |
| 2026-06-22 | 4 | Kapusta Matthew C — CEO, Managing Director, Director | Option exercise (M): 62,581 @ $19.39 · Sale (S): 23,977 @ $42.61 · Sale (S): 6,023 @ $43.70 · Sale (S): 32,581 @ $45.02 · Sale (S): 56,929 @ $43.43 · Sale (S): 33,334 @ $45.01 · +6 more | EDGAR |
| 2026-06-22 | 4 | Kaye Jack — Director | Option exercise (M): 5,295 @ $31.71 · Sale (S): 5,295 @ $42.57 · Option exercise (M): 5,295 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Potts Jeannette — Chief Legal Officer | Sale (S): 5,237 @ $27.67 | EDGAR |
| 2026-06-17 | 4 | Balachandran Madhavan — Director | Option exercise (M): 10,000 @ $8.49 · Sale (S): 10,000 @ $27.85 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Gut Robert — Director | Option exercise (M): 2,645 @ $16.04 · Sale (S): 2,645 @ $26.07 · Sale (S): 3,127 @ $26.03 · Sale (S): 1,780 @ $26.05 · Grant/award (A): 7,550 @ $0 · Sale (S): 2,726 @ $27.06 · +2 more | EDGAR |
| 2026-06-12 | 4 | O'Keefe Kylie — Chief Customer & Strat Officer | Sale (S): 15,936 @ $27.06 | EDGAR |
| 2026-06-12 | 4 | Springhorn Jeremy P. — Director | Grant/award (A): 7,550 @ $0 · Sale (S): 1,993 @ $27.06 · Grant/award (A): 13,980 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Jacques Rachelle Suzanne — Director | Grant/award (A): 7,550 @ $0 · Sale (S): 1,993 @ $27.06 · Grant/award (A): 13,980 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Balachandran Madhavan — Director | Grant/award (A): 7,550 @ $0 · Sale (S): 1,993 @ $27.06 · Grant/award (A): 13,980 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Meek David D. — Director | Grant/award (A): 7,550 @ $0 · Sale (S): 1,993 @ $27.06 · Grant/award (A): 13,980 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Kaye Jack — Director | Grant/award (A): 7,550 @ $0 · Sale (S): 1,993 @ $27.06 · Grant/award (A): 13,980 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | POST LEONARD E — Director | Grant/award (A): 7,550 @ $0 · Sale (S): 1,993 @ $27.06 · Grant/award (A): 13,980 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Kaye Jack — Director | Option exercise (M): 2,645 @ $16.04 · Sale (S): 2,645 @ $30.01 · Option exercise (M): 2,645 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Abi-Saab Walid — Chief Medical Officer | Option exercise (M): 25,000 @ $5.59 · Sale (S): 25,000 @ $25.10 · Sale (S): 20,000 @ $25 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | O'Keefe Kylie — Chief Customer & Strat Officer | Grant/award (A): 19,800 @ $0 · Grant/award (A): 31,900 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Abi-Saab Walid — Chief Medical Officer | Grant/award (A): 41,700 @ $0 · Sale (S): 808 @ $9.06 · Grant/award (A): 67,200 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Potts Jeannette — Chief Legal Officer | Grant/award (A): 35,400 @ $0 · Sale (S): 3,412 @ $9.06 · Grant/award (A): 57,200 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | KLEMT CHRISTIAN — Chief Financial Officer | Grant/award (A): 39,600 @ $0 · Sale (S): 12,000 @ $9.06 · Grant/award (A): 63,900 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Kapusta Matthew C — CEO, Managing Director, Director | Grant/award (A): 70,600 @ $0 · Sale (S): 14,581 @ $9.06 · Grant/award (A): 113,800 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | KLEMT CHRISTIAN — Chief Financial Officer | Sale (S): 12,532 @ $9.95 | EDGAR |
| 2026-03-04 | 4 | Potts Jeannette — Chief Legal Officer | Sale (S): 8,578 @ $9.95 | EDGAR |
| 2026-03-04 | 4 | Abi-Saab Walid — Chief Medical Officer | Sale (S): 1,660 @ $9.95 | EDGAR |
| 2026-03-04 | 4 | Kapusta Matthew C — CEO, Managing Director, Director | Sale (S): 34,437 @ $9.95 | EDGAR |
| 2026-02-27 | 4 | KLEMT CHRISTIAN — Chief Financial Officer | Sale (S): 6,217 @ $23.86 | EDGAR |
| 2026-02-27 | 4 | Kapusta Matthew C — CEO, Managing Director, Director | Sale (S): 12,378 @ $23.86 | EDGAR |
| 2026-01-14 | 4 | Gut Robert — Director | Option exercise (M): 17,810 @ $14.08 · Sale (S): 17,310 @ $24.39 · Sale (S): 500 @ $25.03 · Sale (S): 7,803 @ $25.09 · Option exercise (M): 17,810 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | Kaye Jack — Director | Option exercise (M): 6,390 @ $19.39 · Sale (S): 6,390 @ $27.28 · Option exercise (M): 6,390 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Gut Robert — Director | Option exercise (M): 15,840 @ $4.57 · Sale (S): 15,840 @ $27.22 · Sale (S): 15,594 @ $27.30 · Option exercise (M): 15,840 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | Kaye Jack — Director | Option exercise (M): 10,000 @ $7.37 · Sale (S): 10,000 @ $30.36 · Option exercise (M): 11,000 @ $5.37 · Sale (S): 11,000 @ $30.34 · Option exercise (M): 17,810 @ $14.08 · Sale (S): 17,810 @ $30.33 · +3 more | EDGAR |
| 2025-09-26 | 4 | KLEMT CHRISTIAN — Chief Financial Officer | Option exercise (M): 3,000 @ $13.03 · Sale (S): 3,000 @ $40.04 · Option exercise (M): 15,000 @ $5.37 · Sale (S): 15,000 @ $55 · Option exercise (M): 3,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-09-26 | 4 | Kapusta Matthew C — CEO, Managing Director, Director | Option exercise (M): 51,316 @ $7.53 · Option exercise (M): 175,000 @ $6.22 · Sale (S): 51,316 @ $39.59 · Sale (S): 60,000 @ $40.04 · Sale (S): 49,978 @ $40.68 · Sale (S): 5,022 @ $41.69 · +3 more | EDGAR |
| 2025-07-01 | 4 | Abi-Saab Walid — Chief Medical Officer | Sale (S): 1,466 @ $13.92 | EDGAR |
| 2025-06-24 | 4 | Springhorn Jeremy P. — Director | Sale (S): 2,112 @ $14.45 | EDGAR |
| 2025-06-24 | 4 | Jacques Rachelle Suzanne — Director | Sale (S): 2,112 @ $14.45 | EDGAR |
| 2025-06-24 | 4 | Gut Robert — Director | Sale (S): 3,336 @ $14.45 | EDGAR |
| 2025-06-24 | 4 | Balachandran Madhavan — Director | Sale (S): 2,112 @ $14.45 | EDGAR |
| 2025-06-24 | 4 | Meek David D. — Director | Sale (S): 2,112 @ $14.45 | EDGAR |
| 2025-06-24 | 4 | Kaye Jack — Director | Sale (S): 2,112 @ $14.45 | EDGAR |
| 2025-06-24 | 4 | POST LEONARD E — Director | Sale (S): 2,112 @ $14.45 | EDGAR |
| 2025-06-20 | 4 | Potts Jeannette — Chief Legal Officer | Sale (S): 4,670 @ $15.14 | EDGAR |
| 2025-06-13 | 4 | Jacques Rachelle Suzanne — Director | Grant/award (A): 7,970 @ $0 · Grant/award (A): 15,630 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Gut Robert — Director | Grant/award (A): 7,970 @ $0 · Grant/award (A): 15,630 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Springhorn Jeremy P. — Director | Grant/award (A): 7,970 @ $0 · Grant/award (A): 15,630 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Balachandran Madhavan — Director | Grant/award (A): 7,970 @ $0 · Grant/award (A): 15,630 (derivative) @ $0 | EDGAR |
Recent 8-K events — uniQure N.V.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-13 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=QURE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →